Equillium Inc (EQ)

Equillium (EQ) Stock Price & Analysis


EQ Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.48 - $3.20
Previous Close$0.62
Average Volume (3M)152.39K
Market Cap
Enterprise Value-$31.21M
Total Cash (Recent Filing)$61.99M
Total Debt (Recent Filing)$8.68M
Price to Earnings (P/E)-0.7
Aug 14, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.84
Shares Outstanding34,414,149
10 Day Avg. Volume147,240
30 Day Avg. Volume152,389
Standard Deviation0.36
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)2.38
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-1.27
Enterprise Value/Gross Profit-1.98
Enterprise Value/Ebitda1.08
Price Target Upside807.32% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Equillium Inc’s price range in the past 12 months?
Equillium Inc lowest stock price was $0.48 and its highest was $3.20 in the past 12 months.
    What is Equillium Inc’s market cap?
    Currently, no data Available
    When is Equillium Inc’s upcoming earnings report date?
    Equillium Inc’s upcoming earnings report date is Aug 14, 2023 which is in 74 days.
      How were Equillium Inc’s earnings last quarter?
      Equillium Inc released its earnings results on May 11, 2023. The company reported -$0.11 earnings per share for the quarter, beating the consensus estimate of -$0.21 by $0.1.
        Is Equillium Inc overvalued?
        According to Wall Street analysts Equillium Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Equillium Inc pay dividends?
          Equillium Inc does not currently pay dividends.
          What is Equillium Inc’s EPS estimate?
          Equillium Inc’s EPS estimate is -$0.17.
            How many shares outstanding does Equillium Inc have?
            Equillium Inc has 34,414,150 shares outstanding.
              What happened to Equillium Inc’s price movement after its last earnings report?
              Equillium Inc reported an EPS of -$0.11 in its last earnings report, beating expectations of -$0.21. Following the earnings report the stock price went up 1.754%.
                Which hedge fund is a major shareholder of Equillium Inc?
                Among the largest hedge funds holding Equillium Inc’s share is Cota Capital Management, LLC. It holds Equillium Inc’s shares valued at 410K.


                  Equillium Stock Smart Score

                  This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Equillium Inc

                  Equillium, Inc. is a biotechnology company, which engages in the development of products for severe immuno-inflammatory disorders with high unmet medical need. Its product pipeline include EQ001, is a monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. The company was founded by Daniel Mark Bradbury, Bruce D. Steel, and Stephen Connelly on March 16, 2017 and is headquartered in La Jolla, CA.


                  Top 5 ETFs holding EQ

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  iShares Core S&P Total U.S. Stock Market ETF
                  Up to five ETFs with an Outperform Smart Score that hold EQ. The ETFs are listed according to market value of EQ within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Rockwell Med
                  Aurinia Pharmaceuticals
                  Karyopharm Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis